548 results on '"Grayson, Peter C."'
Search Results
102. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease
103. Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease
104. Myelodysplasia and Bone Marrow Manifestations of Somatic UBA1 Mutated Autoinflammatory Disease
105. Somatic Mutations in a Single Residue of UBA1 Cause Vexas, a Severe Adult-Onset Rheumatic Disease Associated with Myeloid Dysplasia
106. Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis
107. Reply
108. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis.
109. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis.
110. Pulmonary involvement in primary systemic vasculitides.
111. Distribution of arterial lesions in Takayasuʼs arteritis and giant cell arteritis
112. Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis
113. Outcome Measures in Large Vessel Vasculitis: Relationship Between Patient‐, Physician‐, Imaging‐, and Laboratory‐Based Assessments
114. Patterns of clinical presentation in Takayasu's arteritis
115. Defining Clinical Subgroups in Relapsing Polychondritis: A Prospective Observational Cohort Study
116. Utility of the Brief Illness Perception Questionnaire to Monitor Patient Beliefs in Systemic Vasculitis
117. Diagnostic Assessment Strategies and Disease Subsets in Giant Cell Arteritis: Data From an International Observational Cohort
118. Imaging acquisition technique influences interpretation of positron emission tomography vascular activity in large-vessel vasculitis
119. Comment on: Derivation of an angiographically based classification system in Takayasu’s arteritis: reply
120. Clinical symptoms and associated vascular imaging findings in Takayasu’s arteritis compared to giant cell arteritis
121. Derivation of an angiographically based classification system in Takayasu’s arteritis: an observational study from India and North America
122. Reply LTE, On Semi-quantitative Methods for Assessing Vascular 18FDG-PET Activity in Large- Vessel Vasculitis.
123. Comparing Semi-quantitative and Qualitative Methods of Vascular FDG-PET Activity Measurement in Large-Vessel Vasculitis.
124. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease
125. Use of 18F-fluorodeoxyglucose positron emission tomography to monitor tocilizumab effect on vascular inflammation in giant cell arteritis.
126. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.
127. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis.
128. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Polyarteritis Nodosa.
129. Automated plaque detection and Agatston score estimation on non-contrast CT scans: a multicenter study
130. Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease.
131. Positron Emission Tomography as an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients with Large Vessel Vasculitis
132. Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis
133. Vascular calcification in patients with large-vessel vasculitis compared to patients with hyperlipidemia
134. Patient-perceived Burden of Disease in Pediatric Relapsing Polychondritis
135. MultiPLIER: A Transfer Learning Framework for Transcriptomics Reveals Systemic Features of Rare Disease
136. Stenosis and Pseudostenosis of the Upper Extremity Arteries in Large‐Vessel Vasculitis
137. Sarcoidosis Concomitant With Takayasu Arteritis, Identified by Advanced Molecular Imaging
138. Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis
139. 084. DISCOVERY AND VALIDATION OF A NOVEL ANGIOGRAPHIC CLASSIFICATION SCHEME IN TAKAYASU’S ARTERITIS
140. Effects of the COVID‐19 Pandemic on Patients Living With Vasculitis.
141. Response to: Correspondence on '2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis' by Joanna C Robson et al and '2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis' by Pimentel-Quiroz et al
142. Ruxolitinib is more effective than other JAK Inhibitors to treat VEXAS Syndrome: a retrospective multi center study
143. Venous and Arterial Thrombosis in Patients with VEXAS Syndrome
144. Protocol for a randomized multicenter study for isolated skin vasculitis (ARAMIS) comparing the efficacy of three drugs: azathioprine, colchicine, and dapsone.
145. Clinical symptoms and associated vascular imaging findings in Takayasu's arteritis compared to giant cell arteritis.
146. Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-vessel Vasculitis.
147. Drug-induced lupus: Traditional and new concepts
148. MultiPLIER: a transfer learning framework for transcriptomics reveals systemic features of rare disease
149. Characterisation of the nasal microbiota in granulomatosis with polyangiitis
150. Patient Perception of Disease-Related Symptoms and Complications in Relapsing Polychondritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.